{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:29:14Z","timestamp":1793946554643,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eclinm.2026.104034","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:13:06Z","timestamp":1783005186000},"page":"104034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High-frequency irreversible electroporation versus transurethral resection of the prostate for benign prostatic hyperplasia (GIANT): a single-centre, randomised, double-blind, phase 3, non-inferiority trial"],"prefix":"10.1016","volume":"97","author":[{"given":"Bi-Ming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Chao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Kai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Sun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ling","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2026.104034_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104034_bib2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.eururo.2014.01.019","article-title":"What is the Most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women","volume":"65","author":"Agarwal","year":"2014","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104034_bib3","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","article-title":"The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"3","author":"Awedew","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.eclinm.2026.104034_bib4","series-title":"EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2024","author":"Cornu","year":"2024"},{"key":"10.1016\/j.eclinm.2026.104034_bib5","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","article-title":"A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update","volume":"67","author":"Cornu","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104034_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.juro.2008.03.058","article-title":"Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients","volume":"180","author":"Reich","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eclinm.2026.104034_bib7","article-title":"Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis","volume":"367","author":"Huang","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.104034_bib8","doi-asserted-by":"crossref","first-page":"a1662","DOI":"10.1136\/bmj.a1662","article-title":"Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials","volume":"337","author":"Lourenco","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104034_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41391-024-00915-y","article-title":"Prostatic stents: a systematic review and analysis of functional outcomes and complication rate","volume":"28","author":"Cerrato","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104034_bib10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10439-020-02462-8","article-title":"Dynamics of cell death after conventional IRE and H-FIRE treatments","volume":"48","author":"Mercadal","year":"2020","journal-title":"Ann Biomed Eng"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104034_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018831","article-title":"The effects of irreversible electroporation (IRE) on nerves","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104034_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bju.12227","article-title":"Bilateral focal ablation of prostate tissue using low-energy direct current (LEDC): a preclinical canine study","volume":"112","author":"Tsivian","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.eclinm.2026.104034_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamasurg.2022.2230","article-title":"Extended focal ablation of localized prostate cancer with high-frequency irreversible electroporation: a nonrandomized controlled trial","volume":"157","author":"Wang","year":"2022","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104034_bib14","volume":"15","author":"He","year":"2025","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104034_bib15","first-page":"1549","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Mj","year":"1992","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104034_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rc","year":"1999","journal-title":"Int J Impot Res"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104034_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0895-4356(98)00044-4","article-title":"Sexual dysfunction in men with lower urinary tract symptoms","volume":"51","author":"Sj","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104034_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/nau.20041","article-title":"ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence","volume":"23","author":"Avery","year":"2004","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104034_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Jt","year":"2000","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104034_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"As","year":"1983","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104034_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jamcollsurg.2005.03.034","article-title":"Visual analog scales for assessing surgical pain","volume":"201","author":"McCarthy","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104034_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41391-025-00939-y","article-title":"The evolving landscape of BPH surgical treatments: considering semen parameters in clinical decision-making","volume":"29","author":"Valdivia Y Alvarado","year":"2026","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eclinm.2026.104034_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.urology.2025.03.029","article-title":"Efficacy and safety of high-frequency irreversible electroporation in benign prostatic hyperplasia: a randomized controlled, open-label, multi-center clinical Study","volume":"201","author":"Tong","year":"2025","journal-title":"Urology"},{"key":"10.1016\/j.eclinm.2026.104034_bib24","article-title":"Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial","volume":"361","author":"Abt","year":"2018","journal-title":"BMJ"},{"issue":"10243","key":"10.1016\/j.eclinm.2026.104034_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(20)30537-7","article-title":"Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial","volume":"396","author":"Hashim","year":"2020","journal-title":"Lancet"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:50:14Z","timestamp":1793944214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026002877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"alternative-id":["S2589537026002877"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104034","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-frequency irreversible electroporation versus transurethral resection of the prostate for benign prostatic hyperplasia (GIANT): a single-centre, randomised, double-blind, phase 3, non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104034"}}